Stock RGLS REGULUS THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Regulus Therapeutics Inc.

Equities

RGLS

US75915K3095

Market Closed - Nasdaq
Other stock markets
 03:59:52 2024-05-30 pm EDT 		5-day change 1st Jan Change
2.265 USD +6.34% Intraday chart for Regulus Therapeutics Inc. +17.97% +76.95%
May. 22 Bio-Techne Corporation and Regulus Therapeutics Inc. Announces Continued Technical and Clinical Collaboration CI
May. 16 Regulus Therapeutics Inc. Announces Promotion of Rekha Garg to Chief Medical Officer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
REGULUS THERAPEUTICS INC. Stock Regulus Therapeutics Inc.
 139M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 104B
ARGENX SE Stock argenx SE
 22.57B -
BIONTECH SE Stock BioNTech SE
 22.5B -
GENMAB A/S Stock Genmab A/S
 17.95B
  1. Stock Market
  2. Equities
  3. RGLS Stock
  4. Charts Regulus Therapeutics Inc.
  5. Sector Chart